Registration Document 2017
2017 Annual Results
SCOR has been named “Reinsurer of the Year” for 2017 by InsuranceERM
SCOR has completed the increase of its stake in MutRé S.A. to 100%.
Se l’incidenza delle valvulopatie è poco rilevante osservando la popolazione in generale, attestandosi al 2,5% circa, fra i pazienti di età superiore a 75 anni la percentuale sale al 10 - 15%.
Die Prävalenz von Herzklappenerkrankungen in der Allgemeinbevölkerung ist mit ungefähr 2,5% niedrig. Bei den über 75-Jährigen liegt sie mit 10-15% wesentlich höher
Biography of Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life
Third Quarter and First Nine Months 2017 Results
Diabetes 4 key messages for today - Type 1 and 2 diabetes
SCOR was honored twice at Reactions magazine’s North American Awards, during a ceremony held in New York on September 28, 2017.
One year after the launch of its new three-year strategic plan, SCOR has successfully executed the first phase of “Vision in Action”.